Badanie metylacji DNA genu RELN u irackiego dzieci z epilepsją: porównanie pacjentów i zdrowych osób
DNA methylation profiling of the RELN gene using MSP in Iraqi pediatric patients with epilepsy: A case-control study
W skrócie
Naukowcy zbadali zmianę chemiczną (metylację) genu RELN u dzieci z epilepsją i porównali je ze zdrowymi dziećmi. Okazało się, że dzieci z epilepsją mają znacznie wyższy poziom tej chemicznej zmiany w genie RELN, co może być użytecznym markerem do rozpoznawania epilepsji. Gen RELN jest ważny dla prawidłowego rozwoju mózgu i połączeń między neuronami, dlatego jego zmieniona chemiczna struktura może przyczyniać się do rozwoju epilepsji.
Oryginalny abstract (angielski)
BACKGROUND: Epilepsy is one of the most common neurological disorders in children and is influenced by both genetic and epigenetic mechanisms. Altered DNA methylation may contribute to disease susceptibility through changes in gene regulation. The RELN gene is involved in neuronal migration, synaptic plasticity, and brain development, making it a potential target for epigenetic investigation. OBJECTIVE: This study aimed to evaluate the association between RELN methylation levels and pediatric epilepsy and to investigate its potential diagnostic value. METHODS: A case-control study was conducted involving 47 pediatric epilepsy patients and 39 healthy controls. Genomic DNA was extracted and validated prior to methylation analysis. Quantitative real-time PCR using methylation-specific primers was performed to determine RELN methylation percentage. Statistical analyses included Mann-Whitney testing, logistic regression analysis, receiver operating characteristic (ROC) curve analysis, and Spearman correlation analysis. RESULTS: RELN methylation percentage was significantly higher in patients compared with controls (11.60% [8.88-14.61] vs. 7.77% [6.87-10.73], P < 0.0001). ROC analysis demonstrated good discriminatory performance with an AUC of 0.811 (95% CI: 0.712-0.887), sensitivity of 80.85%, and specificity of 74.36% at a cutoff value > 8.545%. Logistic regression analysis identified RELN methylation as an independent predictor of epilepsy (adjusted OR=1.537, 95% CI: 1.240-1.906, P < 0.001). No significant correlations were observed between RELN methylation and age, age at first seizure, or days since the last seizure. CONCLUSION: Increased RELN methylation was significantly associated with pediatric epilepsy and independently predicted disease status, suggesting a potential role for RELN methylation as an epigenetic biomarker in epilepsy.